greeksoup/ stock research
Stock research / United States / Funds / Silverback Asset Management LLC

Silverback Asset Management LLC

CIK 1278960 · latest 13F filed 13 August 2026 · Read the filing on EDGAR

Silverback Asset Management LLC reported 13 US-listed holdings worth $26.8 million in its 13F for the quarter ended 30 June 2026, filed 13 August 2026. Its largest: Harmonic Inc. (32.0%), Vroom Inc. (12.9%) and Core Scientific, Inc. (12.6%). Against the quarter before, it opened 1 position, added to 1, trimmed 6 and sold out of 2.

Reported holdings$26.8M-0.0% on Q1 2026
Positions13-1 on Q1 2026
The largest ten96.1%of its reported holdings
Latest 13FQ2 2026filed 13 August 2026
Where the money is
OpenedAdded toHeldTrimmed
HLIT32.0%VRM12.9%CORZ12.6%WULF8.9%ASTS8.0%AVAV7.5%TEM6.2%LPSN3.4%EYPT2.7%MX1.8%OCGN1.4%ARAY1.4%KPTI1.1%

The 13 largest of its 13 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $22.4 million in 13 positions$22.4MQ3 24Q4 2024: $13.7 million in 5 positions$13.7MQ4 24Q1 2025: $12.5 million in 3 positions$12.5MQ1 25Q2 2025: $25.1 million in 12 positions$25.1MQ2 25Q3 2025: $35.3 million in 11 positions$35.3MQ3 25Q4 2025: $36.2 million in 15 positions$36.2MQ4 25Q1 2026: $26.8 million in 14 positions$26.8MQ1 26Q2 2026: $26.8 million in 13 positions$26.8MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned -37.5% over the 6 quarters to 30 June 2026, against +27.4% for the S&P 500.

Its reported holdingsThe S&P 500
5075100125Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings -37.5%S&P 500 +27.4%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 1Added 1Held 5Trimmed 6Sold out 2
Opened: 1Added: 1Held: 5Trimmed: 6Sold out: 2

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 1

  1. Ocugen Inc. OCGN$382,500

Added to 1

  1. Vroom Inc. VRM+11,300 shares · +3%

Trimmed 6

  1. Harmonic Inc. HLIT-123,566 shares · -19%
  2. Core Scientific, Inc. CORZ-29,300 shares · -18%
  3. Magnachip Semiconductor Corp. MX-120,000 shares · -55%
  4. Tempus AI, Inc. TEM-7,000 shares · -20%
  5. Karyopharm Therapeutics Inc. KPTI-35,000 shares · -54%
  6. Accuray Inc. ARAY-200,000 shares · -12%

Sold out of 2

  1. Neogenomics Inc. NEO$1.2 million last quarter
  2. Scorpio Tankers Inc. STNG$746,600 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Harmonic Inc. HLIT525.0K$8.6 million32.04%-123.6K
Vroom Inc. VRM449.2K$3.5 million12.93%+11.3K
Core Scientific, Inc. CORZ131.6K$3.4 million12.59%-29.3K
Terawulf Inc. WULF96.6K$2.4 million8.92%no change
AST SpaceMobile, Inc. ASTS24.2K$2.2 million8.04%no change
AeroVironment Inc. AVAV12.1K$2.0 million7.47%no change
Tempus AI, Inc. TEM28.7K$1.7 million6.21%-7.0K
Liveperson Inc. Com LPSN485.0K$921,5023.44%no change
Eyepoint Pharmaceuticals Inc. EYPT50.0K$715,0002.67%no change
Magnachip Semiconductor Corp. MX100.0K$473,0001.77%-120.0K
Ocugen Inc. OCGN250.0K$382,5001.43%new
Accuray Inc. ARAY1.4M$373,8101.40%-200.0K
Karyopharm Therapeutics Inc. KPTI30.0K$293,1001.10%-35.0K
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 2 it sold out of are in the box above.

Options it reported

CompanyOptionShares under the optionsValue of those shares
iShares Russell 2000 ETF IWMCalls275.0K$82.6 million
Definium Therapeutics Inc. DFTXCalls294.4K$13.8 million
Cytokinetics Inc. CYTKCalls100.0K$8.5 million
Select Sector SPDR Trust XLVCalls50.0K$7.9 million
SPDR Ser Trust XBICalls50.0K$7.9 million
Nutanix, Inc. NTNXCalls100.0K$5.1 million
Lucid Group, Inc. LCIDPuts470.0K$3.1 million
Par Technology Corp. PARCalls150.0K$2.6 million
Eyepoint Pharmaceuticals Inc. EYPTCalls100.0K$1.4 million
Karyopharm Therapeutics Inc. KPTICalls100.0K$977,000

10 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.